Startup Overview:

Biosplice Therapeutics

Biosplice Therapeutics is a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases. Its scientific platform is based on biological discoveries that govern tissue specialization and enable it to selectively eliminate harmful proteins using small molecules. From the company's foundational discoveries in Wnt pathway modulation to unlocking the broad therapeutic potential of the CLK/DYRK target class, its focus is on the realization of new, potentially curative therapies for patients by selectively reprogramming cellular behavior.

Biosplice Therapeutics
Valuation
$
12
Billion
Country
United States
City
San Diego
Industry
Health
Website
Valuation
$
12
Billion
Country
United States
City
San Diego
Industry
Health
Website

Sign-up for our free weekly newsletter to get regular updates when new startups are added.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.